How does IGF-1 DES work?
Truncated IGF-1 missing the first 3 amino acids. Binds the IGF-1 receptor with normal affinity but has reduced binding to IGFBPs in some tissues. Shorter duration than LR3, often used for site-specific muscle effects. In plain terms, IGF-1 DES is a muscle-growth compound that works more on the local muscle than the whole body. A truncated IGF-1 variant (missing the first 3 amino acids) that acts more locally than IGF-1 LR3, with shorter duration and (in theory) less systemic exposure. Mechanistic detail like this comes largely from preclinical and early research, the human picture is limited.
What people use it for
- Users wanting localized muscle anabolism without LR3-level systemic exposure
- Site-specific injection users
- Short anabolism windows
References
- Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats — Tomas FM, Knowles SE, Owens PC, et al., Biochemical Journal, 1992
- Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy — Yoshida T & Delafontaine P, Cells, 2020
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on IGF-1 DES
Last updated 2026-06-06.